Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-014080
Filing Date
2022-05-17
Accepted
2022-05-17 07:00:49
Documents
32
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form6k.htm   iXBRL 6-K 27044
2 ex99-1.htm EX-99.1 31298
3 ex99-2.htm   iXBRL EX-99.2 318827
4 ex99-3.htm EX-99.3 152769
  Complete submission text file 0001493152-22-014080.txt   1900869

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vblt-20220331.xsd EX-101.SCH 15886
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vblt-20220331_cal.xml EX-101.CAL 33064
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vblt-20220331_def.xml EX-101.DEF 35713
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vblt-20220331_lab.xml EX-101.LAB 164003
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vblt-20220331_pre.xml EX-101.PRE 108958
26 EXTRACTED XBRL INSTANCE DOCUMENT form6k_htm.xml XML 104364
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 22932211
SIC: 2834 Pharmaceutical Preparations